Aptamer-Functionalized Nanomaterials for Circulating Tumor Cell Detection: From Liquid Biopsy to Cancer theranostic.
Advanced nanomaterials improve detection of rare circulating tumor cells, supporting early cancer screening and treatment monitoring.
Circulating tumor cells (CTCs) are important biomarkers in liquid biopsy for early cancer screening, prognosis evaluation, treatment monitoring, and prediction of metastatic risk; however, their extremely low abundance a... Finally, outstanding challenges in analytical robustness, biosafety, in vivo delivery, and clinical translation are discussed, and future directions toward multiplexed analysis, dynamic monitoring, and personalized preci...
What the study was
- Study design
- Observational/unspecified
- Population
- cancer patients
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Analytical biochemistry
Why it surfaced
Score 5/10 [EARLY_CANCER_DETECTION]: Observational/unspecified (Journal Article) matched 'Early cancer detection (liquid biopsy, c'. Components — novelty:1/3, relevance:2/3, design:1/2, population:1/2. Confidence: medium. Conservative scoring applied per v1.3 rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.